Clinical trial
Cholesterol Lowering Level of MK0653A+Simvastatin in Patients With…
NCT00090168 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00090168 |
|---|---|
| Title | Cholesterol Lowering Level of MK0653A+Simvastatin in Patients With Hypercholesterolemia and Atherosclerotic or Coronary Vascular Disease (0653A-806)(COMPLETED) |
| Official title | A Multicenter Study to Assess the Cholesterol Lowering Level of Switching to an Investigational Drug Compared to Doubling the Dose of an Investigational Drug in Patients With Hypercholesterolemia and Atherosclerotic or Coronary Vascular Disease |
| Lead sponsor | Organon and Co, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypercholesterolemia, Atherosclerotic Disease, Coronary Disease |
| Intervention type | Drug |
| Interventions | MK0653A, ezetimibe (+) simvastatin, Comparator: atorvastatin, Duration of Treatment: 6 weeks |
| Enrollment | 435 |
| Start date | Jan 27, 2004 |
| Primary completion | Oct 20, 2004 |
| Completion | Nov 10, 2004 |
| First posted | Aug 27, 2004 |
| Last update posted | Aug 15, 2024 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: